These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 33294462)
1. The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model. Nakhoul N; Thawko T; Farber E; Dahan I; Tadmor H; Nakhoul R; Hanut A; Salameh G; Shagrawy I; Nakhoul F J Diabetes Res; 2020; 2020():7907605. PubMed ID: 33294462 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway. Li A; Yi B; Han H; Yang S; Hu Z; Zheng L; Wang J; Liao Q; Zhang H Autophagy; 2022 Apr; 18(4):877-890. PubMed ID: 34432556 [TBL] [Abstract][Full Text] [Related]
3. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell. Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769 [TBL] [Abstract][Full Text] [Related]
4. Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Sanchez-Niño MD; Bozic M; Córdoba-Lanús E; Valcheva P; Gracia O; Ibarz M; Fernandez E; Navarro-Gonzalez JF; Ortiz A; Valdivielso JM Am J Physiol Renal Physiol; 2012 Mar; 302(6):F647-57. PubMed ID: 22169009 [TBL] [Abstract][Full Text] [Related]
5. VDR Activation Reduces Proteinuria and High-Glucose-Induced Injury of Kidneys and Podocytes by Regulating Wnt Signaling Pathway. Guo J; Lu C; Zhang F; Yu H; Zhou M; He M; Wang C; Zhao Z; Liu Z Cell Physiol Biochem; 2017; 43(1):39-51. PubMed ID: 28848172 [TBL] [Abstract][Full Text] [Related]
7. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Zhang X; Song Z; Guo Y; Zhou M Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Wang S; Li Y; Zhao J; Zhang J; Huang Y Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166 [TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy. Zeng JY; Wang Y; Hong FY; Miao M; Jiang YY; Qiao ZX; Wang YT; Bao XR Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3959-3977. PubMed ID: 37991543 [TBL] [Abstract][Full Text] [Related]
10. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678 [TBL] [Abstract][Full Text] [Related]
11. Paricalcitol modulates ACE2 shedding and renal ADAM17 in NOD mice beyond proteinuria. Riera M; Anguiano L; Clotet S; Roca-Ho H; Rebull M; Pascual J; Soler MJ Am J Physiol Renal Physiol; 2016 Mar; 310(6):F534-46. PubMed ID: 26697977 [TBL] [Abstract][Full Text] [Related]
12. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571 [TBL] [Abstract][Full Text] [Related]
13. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. He W; Kang YS; Dai C; Liu Y J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600 [TBL] [Abstract][Full Text] [Related]
14. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats. Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease. Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D and proteinuria: a critical review of molecular bases and clinical experience. Pérez-Gómez MV; Ortiz-Arduán A; Lorenzo-Sellares V Nefrologia; 2013; 33(5):716-26. PubMed ID: 24089164 [TBL] [Abstract][Full Text] [Related]
17. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats. Tian W; Lei H; Guan R; Xu Y; Li H; Wang L; Yang B; Gao Z; Xin Z Drug Des Devel Ther; 2015; 9():5147-57. PubMed ID: 26379427 [TBL] [Abstract][Full Text] [Related]
18. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice. You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709 [TBL] [Abstract][Full Text] [Related]
19. Exogenous activated protein C inhibits the progression of diabetic nephropathy. Gil-Bernabe P; D'Alessandro-Gabazza CN; Toda M; Boveda Ruiz D; Miyake Y; Suzuki T; Onishi Y; Morser J; Gabazza EC; Takei Y; Yano Y J Thromb Haemost; 2012 Mar; 10(3):337-46. PubMed ID: 22236035 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats. Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]